Skip to main content
Clinical Trials/NCT05181111
NCT05181111
Unknown
N/A

Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Rijnstate Hospital1 site in 1 country800 target enrollmentDecember 6, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Monitoring
Sponsor
Rijnstate Hospital
Enrollment
800
Locations
1
Primary Endpoint
Percentage of patients discharged home from acute admission ward
Last Updated
4 years ago

Overview

Brief Summary

Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.

Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.

Registry
clinicaltrials.gov
Start Date
December 6, 2021
End Date
July 1, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rijnstate Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • In order for a patient to be eligible to participate in this study, the following criteria need to be met:
  • admitted to the AAW
  • Age ≥ 18 years
  • Able to speak and read Dutch
  • Willing and able to provide written informed consent

Exclusion Criteria

  • A patient who meets any of the following criteria will be excluded from participation:
  • Not able or willing to wear a wearable sensor on the chest continuously for 14 days
  • Planned major surgery in the upcoming 30 days
  • At the time of AAW admission already known to be discharged home or admitted to the hospital
  • Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed
  • Known sensitivity to medical adhesives
  • Wearing an active implantable device (e.g. ICD, pacemaker)
  • Intend to go to the sauna or go swimming in the upcoming 14 days
  • Pregnant or breastfeeding
  • Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)

Outcomes

Primary Outcomes

Percentage of patients discharged home from acute admission ward

Time Frame: up to 7 days

Percentage of patients discharged home from acute admission ward

Secondary Outcomes

  • Length of stay in the acute admission ward(up to 7 days)
  • Percentage of Intensive Care Unit Admissions(up to 31 days)
  • Length of stay in the in-hospital wards(up to 31 days)
  • Percentage of Rapid Response Team calls(up to 31 days)
  • Percentage of unplanned readmissions to the hospitals(up to 31 days)

Study Sites (1)

Loading locations...

Similar Trials